Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Diandra Martinez-Cano"'
Autor:
Diandra Martinez-Cano, Rashmi Ravichandran, Huong Le, H. Edward Wong, Bharat Jagannathan, Erik J. Liu, William Bailey, Jane Yang, Kelli Matthies, Hedieh Barkhordarian, Bhavana Shah, Nithya Srinivasan, Jun Zhang, Angel Hsu, Jette Wypych, Jennitte Stevens, Deirdre Murphy Piedmonte, Les P. Miranda, Lauren Carter, Michael Murphy, Neil P. King, Neil Soice
Publikováno v:
Process Biochemistry. 129:241-256
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9cdb05762cb3b98d4e5226e4599710f5
https://doi.org/10.1016/j.procbio.2023.03.014
https://doi.org/10.1016/j.procbio.2023.03.014
Autor:
Scott T. Kuhns, David J. Semin, Neil P. Soice, Andy Kappes, H. Edward Wong, Tsang‐Lin Hwang, Robert J. Soto, Andrew T. Csordas, Alexander Wu, Diandra Martinez‐Cano, Melin Babayan, Yesenia Pelayo, Matthew R. Hammond, Yasser Nashed‐Samuel, Chetan T. Goudar
Publikováno v:
Biotechnology progressREFERENCES.
For mammalian cell-derived recombinant biotherapeutics, controlling host cell DNA levels below a threshold is a regulatory requirement to ensure patient safety. DNA removal during drug substance manufacture is accomplished by a series of chromatograp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80fbc44d22852dc84c6b4fb57618bb52
https://pubmed.ncbi.nlm.nih.gov/36282232
https://pubmed.ncbi.nlm.nih.gov/36282232
Autor:
null Scott Kuhns, null David J. Semin, null Neil P. Soice, null Andy Kappes, null H. Edward Wong, null Tsang‐Lin Hwang, null Robert J. Soto, null Andrew T. Csordas, null Alexander Wu, null Diandra Martinez‐Cano, null Melin Babayan, null Yesenia Pelayo, null Matthew R. Hammond, null Yasser Nashed‐Samuel, null Chetan T. Goudar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9ea85929b2b9cd6d84e907cff4787db4
https://doi.org/10.1002/btpr.3307/v2/response1
https://doi.org/10.1002/btpr.3307/v2/response1
Autor:
Wang Yan, Chetan T. Goudar, Jonathan Lull, Mike Pritchard, Natalia Gomez, Diandra Martinez Cano, Xin Zhang, John Harrahy, Xiaorui Yang, Agatha Wieczorek, Michael Shearer
Publikováno v:
Biotechnology Progress. 36
Bispecific protein scaffolds can be more complex than traditional monoclonal antibodies (MAbs) because two different sites/domains for epitope binding are needed. Because of this increased molecular complexity, bispecific molecules are difficult to e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c51aa252279b421f27728486a236f549
https://doi.org/10.1002/btpr.2973
https://doi.org/10.1002/btpr.2973